The following text field will produce suggestions that follow it as you type.

Loading Inventory...

Barnes and Noble

Commercializing Biobased Products: Opportunities, Challenges, Benefits, and Risks

Current price: $224.00
Commercializing Biobased Products: Opportunities, Challenges, Benefits, and Risks
Commercializing Biobased Products: Opportunities, Challenges, Benefits, and Risks

Barnes and Noble

Commercializing Biobased Products: Opportunities, Challenges, Benefits, and Risks

Current price: $224.00
Loading Inventory...

Size: OS

Visit retailer's website
*Product Information may vary - to confirm product availability, pricing, and additional information please contact Barnes and Noble
Biobased products offer substantial economic and environmental benefits, but understanding how to commercialize this requires a comprehensive look at the process, including feedstocks, technologies, product slate, supply chain, policy, financing, and environmental impact. Covering biobased products in a broad context, this book examines the environmental and economic impacts, compares US and EU policies, explores the factors affecting financing, and considers biological conversion, catalytic conversion, and separations. By examining the process from several critical perspectives in the supply chain, this book provides chemical engineers with a better understanding of challenges, opportunities, risks, and benefits of commercialization.

More About Barnes and Noble at MarketFair Shoppes

Barnes & Noble does business -- big business -- by the book. As the #1 bookseller in the US, it operates about 720 Barnes & Noble superstores (selling books, music, movies, and gifts) throughout all 50 US states and Washington, DC. The stores are typically 10,000 to 60,000 sq. ft. and stock between 60,000 and 200,000 book titles. Many of its locations contain Starbucks cafes, as well as music departments that carry more than 30,000 titles.

Powered by Adeptmind